BACKGROUND: Colorectal cancer (CRC) is the most frequently diagnosed cancer among Alaska Native (AN) people, and the second leading cause of cancer death. The incidence rate for the combined years 1999 through 2003 was 30% higher than the rate among U.S. whites (USWs) for the same period. Current incidence rates may serve to monitor the impact of screening programs in reducing CRC in the AN population. METHODS: Incidence data are from the Alaska Native Tumor Registry and the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program. We compared AN CRC incidence, survival rates, and stage at diagnosis with rates in USWs for cases diagnosed from 2005 through 2009. Relative survival calculations were produced in SEER*Stat by the actuarial method. RESULTS: The CRC age-adjusted incidence rate among AN men and women combined was higher than those in USW men and women (84 vs. 43/100,000; P < .05; AN:USW rate ratio [RR] = 2.0). The greatest differences between rates in AN people and USWs were for tumors in the hepatic flexure (RR = 3.1) and in the transverse (RR = 2.9) and sigmoid (RR = 2.5) regions of the colon. Rectal cancer rates among AN people were significantly higher than rates in USWs (21 vs.12/100,000). Five-year relative survival proportions by stage at diagnosis indicate that the CRC 5-year relative survival was similar in AN people and USWs for the period 2004 through 2009. CONCLUSIONS: The high rate of CRC in AN people emphasizes the need for screening programs and interventions to reduce known modifiable risks. Research in methods to promote healthy behaviors among AN people is greatly needed.
BACKGROUND:Colorectal cancer (CRC) is the most frequently diagnosed cancer among Alaska Native (AN) people, and the second leading cause of cancer death. The incidence rate for the combined years 1999 through 2003 was 30% higher than the rate among U.S. whites (USWs) for the same period. Current incidence rates may serve to monitor the impact of screening programs in reducing CRC in the AN population. METHODS: Incidence data are from the Alaska Native Tumor Registry and the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program. We compared AN CRC incidence, survival rates, and stage at diagnosis with rates in USWs for cases diagnosed from 2005 through 2009. Relative survival calculations were produced in SEER*Stat by the actuarial method. RESULTS: The CRC age-adjusted incidence rate among AN men and women combined was higher than those in USW men and women (84 vs. 43/100,000; P < .05; AN:USW rate ratio [RR] = 2.0). The greatest differences between rates in AN people and USWs were for tumors in the hepatic flexure (RR = 3.1) and in the transverse (RR = 2.9) and sigmoid (RR = 2.5) regions of the colon. Rectal cancer rates among AN people were significantly higher than rates in USWs (21 vs.12/100,000). Five-year relative survival proportions by stage at diagnosis indicate that the CRC 5-year relative survival was similar in AN people and USWs for the period 2004 through 2009. CONCLUSIONS: The high rate of CRC in AN people emphasizes the need for screening programs and interventions to reduce known modifiable risks. Research in methods to promote healthy behaviors among AN people is greatly needed.
Authors: Xiaocheng Wu; Vilma Cokkinides; Vivien W Chen; Marion Nadel; Yuan Ren; Jim Martin; Gary L Ellison Journal: Cancer Date: 2006-09-01 Impact factor: 6.860
Authors: A J Parkinson; B D Gold; L Bulkow; R B Wainwright; B Swaminathan; B Khanna; K M Petersen; M A Fitzgerald Journal: Clin Diagn Lab Immunol Date: 2000-11
Authors: Enrique Quintero; Antoni Castells; Luis Bujanda; Joaquín Cubiella; Dolores Salas; Ángel Lanas; Montserrat Andreu; Fernando Carballo; Juan Diego Morillas; Cristina Hernández; Rodrigo Jover; Isabel Montalvo; Juan Arenas; Eva Laredo; Vicent Hernández; Felipe Iglesias; Estela Cid; Raquel Zubizarreta; Teresa Sala; Marta Ponce; Mercedes Andrés; Gloria Teruel; Antonio Peris; María-Pilar Roncales; Mónica Polo-Tomás; Xavier Bessa; Olga Ferrer-Armengou; Jaume Grau; Anna Serradesanferm; Akiko Ono; José Cruzado; Francisco Pérez-Riquelme; Inmaculada Alonso-Abreu; Mariola de la Vega-Prieto; Juana Maria Reyes-Melian; Guillermo Cacho; José Díaz-Tasende; Alberto Herreros-de-Tejada; Carmen Poves; Cecilio Santander; Andrés González-Navarro Journal: N Engl J Med Date: 2012-02-23 Impact factor: 91.245
Authors: P Terry; E Giovannucci; K B Michels; L Bergkvist; H Hansen; L Holmberg; A Wolk Journal: J Natl Cancer Inst Date: 2001-04-04 Impact factor: 13.506
Authors: Doris S M Chan; Rosa Lau; Dagfinn Aune; Rui Vieira; Darren C Greenwood; Ellen Kampman; Teresa Norat Journal: PLoS One Date: 2011-06-06 Impact factor: 3.240
Authors: Sarah H Nash; Gretchen Day; Garrett Zimpelman; Vanessa Y Hiratsuka; Kathryn R Koller Journal: Cancer Causes Control Date: 2019-08-19 Impact factor: 2.506
Authors: Renee F Robinson; Denise A Dillard; Vanessa Y Hiratsuka; Julia J Smith; Steve Tierney; Jaedon P Avey; Dedra S Buchwald Journal: Int J Indig Health Date: 2015
Authors: Soeren Ocvirk; Annette S Wilson; Joram M Posma; Jia V Li; Kathryn R Koller; Gretchen M Day; Christie A Flanagan; Jill Evon Otto; Pam E Sacco; Frank D Sacco; Flora R Sapp; Amy S Wilson; Keith Newton; Faye Brouard; James P DeLany; Marissa Behnning; Corynn N Appolonia; Devavrata Soni; Faheem Bhatti; Barbara Methé; Adam Fitch; Alison Morris; H Rex Gaskins; James Kinross; Jeremy K Nicholson; Timothy K Thomas; Stephen J D O'Keefe Journal: Am J Clin Nutr Date: 2020-02-01 Impact factor: 7.045
Authors: K M Decker; E V Kliewer; A A Demers; K Fradette; N Biswanger; G Musto; B Elias; D Turner Journal: Curr Oncol Date: 2016-08-12 Impact factor: 3.677
Authors: Diana Redwood; Ellen Provost; Ellen D S Lopez; Monica Skewes; Rhonda Johnson; Claudia Christensen; Frank Sacco; Donald Haverkamp Journal: Health Educ Behav Date: 2015-07-08